The United States continues to play a pivotal role in advancing cancer immunotherapy through substantial investments in biotechnology research, clinical development, and precision medicine initiatives. Strong healthcare infrastructure and favorable regulatory pathways have accelerated the adoption of innovative antibody-based treatments across oncology settings. The country's leadership in...
English
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Greek